Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections

Abstract Background Post-COVID-19 syndrome is characterized by diverse symptoms and abnormalities that persist beyond 12 weeks from the onset of acute COVID-19. Severity disease has been associated with more musculoskeletal alterations such as muscle weakness, dyspnea, and distance walking. The aim...

Full description

Bibliographic Details
Main Authors: Dulce González-Islas, Carlos Sánchez-Moreno, Arturo Orea-Tejeda, Samantha Hernández-López, Fernanda Salgado-Fernández, Candace Keirns-Davis, Susana Galicia-Amor, Esperanza Trejo-Mellado, Laura Gochicoa-Rangel, Armando Castorena-Maldonado
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12890-022-02014-x
_version_ 1818252983129866240
author Dulce González-Islas
Carlos Sánchez-Moreno
Arturo Orea-Tejeda
Samantha Hernández-López
Fernanda Salgado-Fernández
Candace Keirns-Davis
Susana Galicia-Amor
Esperanza Trejo-Mellado
Laura Gochicoa-Rangel
Armando Castorena-Maldonado
author_facet Dulce González-Islas
Carlos Sánchez-Moreno
Arturo Orea-Tejeda
Samantha Hernández-López
Fernanda Salgado-Fernández
Candace Keirns-Davis
Susana Galicia-Amor
Esperanza Trejo-Mellado
Laura Gochicoa-Rangel
Armando Castorena-Maldonado
author_sort Dulce González-Islas
collection DOAJ
description Abstract Background Post-COVID-19 syndrome is characterized by diverse symptoms and abnormalities that persist beyond 12 weeks from the onset of acute COVID-19. Severity disease has been associated with more musculoskeletal alterations such as muscle weakness, dyspnea, and distance walking. The aim was to evaluate the impact of invasive mechanical ventilation (IMV) on body composition and investigate risk factors associated with sarcopenia in post-COVID-19 patients three months after moderate or severe COVID-19 infections. Methods Cross-sectional study. 530 patients with PCR-confirmed diagnoses of moderate to severe COVID-19, > 18 years old, oxygen saturation ≤ 93%, PaO2/FiO2 ratio < 300, who required hospitalization and were discharged were included. We excluded those who died before the follow-up visit, declined to participate, or could not be contacted. Results The mean age was 53.79 ± 12.90 years. IMV subjects had lower phase angle and handgrip strength and higher impedance index, frequency of low muscle mass, and low muscle strength than those without IMV. The risk factors of sarcopenia were > 60 years of age, diabetes, obesity, IMV, and prolonged hospital stay. The multivariate model showed that age > 60 years (OR: 4.91, 95% CI: 2.26–10.63), obesity (OR: 3.73, 95% CI: 1.21–11.54), and interaction between prolonged length of hospital stay and IMV (OR: 2.92; 95% CI: 1.21–7.02) were related to a higher risk of sarcopenia. Conclusion Obesity and the interaction between prolonged length of hospital stay and IMV are associated with a higher risk of sarcopenia at 3 months after severe or moderate COVID-19 infection.
first_indexed 2024-12-12T16:32:50Z
format Article
id doaj.art-119ca62b8db745278108d9210cb152c3
institution Directory Open Access Journal
issn 1471-2466
language English
last_indexed 2024-12-12T16:32:50Z
publishDate 2022-06-01
publisher BMC
record_format Article
series BMC Pulmonary Medicine
spelling doaj.art-119ca62b8db745278108d9210cb152c32022-12-22T00:18:44ZengBMCBMC Pulmonary Medicine1471-24662022-06-012211810.1186/s12890-022-02014-xBody composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infectionsDulce González-Islas0Carlos Sánchez-Moreno1Arturo Orea-Tejeda2Samantha Hernández-López3Fernanda Salgado-Fernández4Candace Keirns-Davis5Susana Galicia-Amor6Esperanza Trejo-Mellado7Laura Gochicoa-Rangel8Armando Castorena-Maldonado9Heart Failure and Respiratory Distress Clinic, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”Heart Failure and Respiratory Distress Clinic, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”Heart Failure and Respiratory Distress Clinic, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”Heart Failure and Respiratory Distress Clinic, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”Heart Failure and Respiratory Distress Clinic, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”Heart Failure and Respiratory Distress Clinic, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”Pulmonary Rehabilitation Department, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”Pulmonary Rehabilitation Department, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”Department of Pulmonary Physiology, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”Otorhinolaryngology Department, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”Abstract Background Post-COVID-19 syndrome is characterized by diverse symptoms and abnormalities that persist beyond 12 weeks from the onset of acute COVID-19. Severity disease has been associated with more musculoskeletal alterations such as muscle weakness, dyspnea, and distance walking. The aim was to evaluate the impact of invasive mechanical ventilation (IMV) on body composition and investigate risk factors associated with sarcopenia in post-COVID-19 patients three months after moderate or severe COVID-19 infections. Methods Cross-sectional study. 530 patients with PCR-confirmed diagnoses of moderate to severe COVID-19, > 18 years old, oxygen saturation ≤ 93%, PaO2/FiO2 ratio < 300, who required hospitalization and were discharged were included. We excluded those who died before the follow-up visit, declined to participate, or could not be contacted. Results The mean age was 53.79 ± 12.90 years. IMV subjects had lower phase angle and handgrip strength and higher impedance index, frequency of low muscle mass, and low muscle strength than those without IMV. The risk factors of sarcopenia were > 60 years of age, diabetes, obesity, IMV, and prolonged hospital stay. The multivariate model showed that age > 60 years (OR: 4.91, 95% CI: 2.26–10.63), obesity (OR: 3.73, 95% CI: 1.21–11.54), and interaction between prolonged length of hospital stay and IMV (OR: 2.92; 95% CI: 1.21–7.02) were related to a higher risk of sarcopenia. Conclusion Obesity and the interaction between prolonged length of hospital stay and IMV are associated with a higher risk of sarcopenia at 3 months after severe or moderate COVID-19 infection.https://doi.org/10.1186/s12890-022-02014-xPost-COVID-19SarcopeniaBody compositionInvasive mechanical ventilation
spellingShingle Dulce González-Islas
Carlos Sánchez-Moreno
Arturo Orea-Tejeda
Samantha Hernández-López
Fernanda Salgado-Fernández
Candace Keirns-Davis
Susana Galicia-Amor
Esperanza Trejo-Mellado
Laura Gochicoa-Rangel
Armando Castorena-Maldonado
Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections
BMC Pulmonary Medicine
Post-COVID-19
Sarcopenia
Body composition
Invasive mechanical ventilation
title Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections
title_full Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections
title_fullStr Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections
title_full_unstemmed Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections
title_short Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections
title_sort body composition and risk factors associated with sarcopenia in post covid patients after moderate or severe covid 19 infections
topic Post-COVID-19
Sarcopenia
Body composition
Invasive mechanical ventilation
url https://doi.org/10.1186/s12890-022-02014-x
work_keys_str_mv AT dulcegonzalezislas bodycompositionandriskfactorsassociatedwithsarcopeniainpostcovidpatientsaftermoderateorseverecovid19infections
AT carlossanchezmoreno bodycompositionandriskfactorsassociatedwithsarcopeniainpostcovidpatientsaftermoderateorseverecovid19infections
AT arturooreatejeda bodycompositionandriskfactorsassociatedwithsarcopeniainpostcovidpatientsaftermoderateorseverecovid19infections
AT samanthahernandezlopez bodycompositionandriskfactorsassociatedwithsarcopeniainpostcovidpatientsaftermoderateorseverecovid19infections
AT fernandasalgadofernandez bodycompositionandriskfactorsassociatedwithsarcopeniainpostcovidpatientsaftermoderateorseverecovid19infections
AT candacekeirnsdavis bodycompositionandriskfactorsassociatedwithsarcopeniainpostcovidpatientsaftermoderateorseverecovid19infections
AT susanagaliciaamor bodycompositionandriskfactorsassociatedwithsarcopeniainpostcovidpatientsaftermoderateorseverecovid19infections
AT esperanzatrejomellado bodycompositionandriskfactorsassociatedwithsarcopeniainpostcovidpatientsaftermoderateorseverecovid19infections
AT lauragochicoarangel bodycompositionandriskfactorsassociatedwithsarcopeniainpostcovidpatientsaftermoderateorseverecovid19infections
AT armandocastorenamaldonado bodycompositionandriskfactorsassociatedwithsarcopeniainpostcovidpatientsaftermoderateorseverecovid19infections